CN102077933B - Special dietary seafood special for hyperuricemia patients - Google Patents
Special dietary seafood special for hyperuricemia patients Download PDFInfo
- Publication number
- CN102077933B CN102077933B CN2010102907091A CN201010290709A CN102077933B CN 102077933 B CN102077933 B CN 102077933B CN 2010102907091 A CN2010102907091 A CN 2010102907091A CN 201010290709 A CN201010290709 A CN 201010290709A CN 102077933 B CN102077933 B CN 102077933B
- Authority
- CN
- China
- Prior art keywords
- vitamin
- powder
- polysaccharide
- whole
- several
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 235000005911 diet Nutrition 0.000 title claims abstract description 25
- 201000001431 Hyperuricemia Diseases 0.000 title claims abstract description 24
- 230000000378 dietary effect Effects 0.000 title claims abstract description 21
- 235000014102 seafood Nutrition 0.000 title abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 49
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 48
- 239000005017 polysaccharide Substances 0.000 claims abstract description 48
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 34
- 239000011707 mineral Substances 0.000 claims abstract description 34
- 235000016709 nutrition Nutrition 0.000 claims abstract description 24
- 229940088594 vitamin Drugs 0.000 claims abstract description 21
- 229930003231 vitamin Natural products 0.000 claims abstract description 21
- 235000013343 vitamin Nutrition 0.000 claims abstract description 21
- 239000011782 vitamin Substances 0.000 claims abstract description 21
- 150000001413 amino acids Chemical class 0.000 claims abstract description 16
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 150000004804 polysaccharides Chemical class 0.000 claims description 44
- 235000010755 mineral Nutrition 0.000 claims description 32
- 235000000346 sugar Nutrition 0.000 claims description 31
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 22
- 150000001875 compounds Chemical class 0.000 claims description 21
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 19
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 18
- 235000012054 meals Nutrition 0.000 claims description 18
- 230000035764 nutrition Effects 0.000 claims description 17
- 235000010443 alginic acid Nutrition 0.000 claims description 15
- 229920000615 alginic acid Polymers 0.000 claims description 15
- 235000001014 amino acid Nutrition 0.000 claims description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 13
- 239000011575 calcium Substances 0.000 claims description 13
- 229910052791 calcium Inorganic materials 0.000 claims description 13
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 12
- 241000251730 Chondrichthyes Species 0.000 claims description 11
- 229960003080 taurine Drugs 0.000 claims description 11
- 229920001661 Chitosan Polymers 0.000 claims description 10
- 229920002567 Chondroitin Polymers 0.000 claims description 10
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 claims description 10
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 10
- 241000206575 Chondrus crispus Species 0.000 claims description 9
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims description 9
- 229930064664 L-arginine Natural products 0.000 claims description 9
- 235000014852 L-arginine Nutrition 0.000 claims description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 9
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000783 alginic acid Substances 0.000 claims description 9
- 229960001126 alginic acid Drugs 0.000 claims description 9
- 150000004781 alginic acids Chemical class 0.000 claims description 9
- 229910052742 iron Inorganic materials 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- 235000010408 potassium alginate Nutrition 0.000 claims description 9
- 239000000737 potassium alginate Substances 0.000 claims description 9
- MZYRDLHIWXQJCQ-YZOKENDUSA-L potassium alginate Chemical compound [K+].[K+].O1[C@@H](C([O-])=O)[C@@H](OC)[C@H](O)[C@H](O)[C@@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@@H](O)[C@H]1O MZYRDLHIWXQJCQ-YZOKENDUSA-L 0.000 claims description 9
- 239000011701 zinc Substances 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- -1 fructose oligosaccharides Chemical class 0.000 claims description 8
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 7
- 241001465754 Metazoa Species 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 7
- 235000004279 alanine Nutrition 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 239000011669 selenium Substances 0.000 claims description 7
- 229910052711 selenium Inorganic materials 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 6
- 241000512259 Ascophyllum nodosum Species 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- 241001324819 Dunaliella peircei Species 0.000 claims description 6
- 229930091371 Fructose Natural products 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 claims description 6
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 6
- 229960001231 choline Drugs 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 229910052750 molybdenum Inorganic materials 0.000 claims description 6
- 239000011733 molybdenum Substances 0.000 claims description 6
- 235000001968 nicotinic acid Nutrition 0.000 claims description 6
- 229960003512 nicotinic acid Drugs 0.000 claims description 6
- 239000011664 nicotinic acid Substances 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- 239000013535 sea water Substances 0.000 claims description 6
- 235000019155 vitamin A Nutrition 0.000 claims description 6
- 239000011719 vitamin A Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
- 229940045997 vitamin a Drugs 0.000 claims description 6
- 229940046008 vitamin d Drugs 0.000 claims description 6
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- 229940072056 alginate Drugs 0.000 claims description 5
- 235000010410 calcium alginate Nutrition 0.000 claims description 5
- 239000000648 calcium alginate Substances 0.000 claims description 5
- 229960002681 calcium alginate Drugs 0.000 claims description 5
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 5
- 229910052804 chromium Inorganic materials 0.000 claims description 5
- 239000011651 chromium Substances 0.000 claims description 5
- 235000005152 nicotinamide Nutrition 0.000 claims description 5
- 239000011570 nicotinamide Substances 0.000 claims description 5
- 229960003966 nicotinamide Drugs 0.000 claims description 5
- 235000010413 sodium alginate Nutrition 0.000 claims description 5
- 239000000661 sodium alginate Substances 0.000 claims description 5
- 229940005550 sodium alginate Drugs 0.000 claims description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 4
- 240000002900 Arthrospira platensis Species 0.000 claims description 4
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 4
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims description 4
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 4
- 241000212297 Pelvetia Species 0.000 claims description 4
- 241000196251 Ulva arasakii Species 0.000 claims description 4
- WOYYTQHMNDWRCW-JGWLITMVSA-N [(2r,3r,4r,5s)-2,3,4,5-tetrahydroxy-6-phosphonooxyhexyl] dihydrogen phosphate Chemical compound OP(=O)(O)OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)COP(O)(O)=O WOYYTQHMNDWRCW-JGWLITMVSA-N 0.000 claims description 4
- 235000020247 cow milk Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- 229940082787 spirulina Drugs 0.000 claims description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- 241000206607 Porphyra umbilicalis Species 0.000 claims description 2
- 229930003427 Vitamin E Natural products 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 2
- 235000019165 vitamin E Nutrition 0.000 claims description 2
- 229940046009 vitamin E Drugs 0.000 claims description 2
- 239000011709 vitamin E Substances 0.000 claims description 2
- 235000013305 food Nutrition 0.000 abstract description 18
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 abstract description 16
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 abstract description 16
- 229940116269 uric acid Drugs 0.000 abstract description 16
- 150000002482 oligosaccharides Chemical class 0.000 abstract description 7
- 230000001603 reducing effect Effects 0.000 abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 7
- 201000005569 Gout Diseases 0.000 abstract description 6
- 241000195493 Cryptophyta Species 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000000975 bioactive effect Effects 0.000 abstract 4
- 150000004676 glycans Chemical class 0.000 abstract 3
- 238000002835 absorbance Methods 0.000 abstract 1
- 235000012041 food component Nutrition 0.000 abstract 1
- 235000003715 nutritional status Nutrition 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 20
- 230000006870 function Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 14
- 229910021529 ammonia Inorganic materials 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 230000036039 immunity Effects 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 229920002101 Chitin Polymers 0.000 description 6
- 238000005469 granulation Methods 0.000 description 6
- 230000003179 granulation Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 241001428166 Eucheuma Species 0.000 description 5
- 235000013312 flour Nutrition 0.000 description 5
- 150000002484 inorganic compounds Chemical class 0.000 description 5
- 229910010272 inorganic material Inorganic materials 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 150000002894 organic compounds Chemical class 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 208000029078 coronary artery disease Diseases 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229940063755 folic acid 0.1 mg Drugs 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000001077 hypotensive effect Effects 0.000 description 4
- 229910052748 manganese Inorganic materials 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 229940104933 vitamin E 3 mg Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 208000001953 Hypotension Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000010100 anticoagulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 208000021822 hypotensive Diseases 0.000 description 3
- 238000005213 imbibition Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- UBLAMKHIFZBBSS-UHFFFAOYSA-N 3-Methylbutyl pentanoate Chemical compound CCCCC(=O)OCCC(C)C UBLAMKHIFZBBSS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 241000965254 Apostichopus japonicus Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000879903 Pteria Species 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046337 Urate nephropathy Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 229960002708 antigout preparations Drugs 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-QZABAPFNSA-N beta-D-glucosamine Chemical compound N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-QZABAPFNSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000026758 coronary atherosclerosis Diseases 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000019007 dietary guidelines Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses special dietary seafood special for hyperuricemia patients. The seafood is characterized by being prepared by taking food-derived marine bioactive polysaccharides as main raw materials, adding algae powder and mixing the food-derived marine bioactive polysaccharides and the algae powder with the auxiliary materials including nutritional amino acids, oligosaccharides, vitamins and minerals. The seafood can be powdery or granular and is eaten after being dissolved in warm water. The seafood is easy to dissolve, has maximum biological absorbance and maximum bioavailability in human bodies, provides marine active factors and nutritional components for human bodies, supplements various vitamins and minerals essential to human bodies, is beneficial to improving the nutritional status of the hyperuricemia patients and can assist in reducing the uric acid level and controlling the hyperuricemia level, improving the immune of the human bodies and preventing gout through synergy of such factors as bioactive components in the food-derived marine bioactive polysaccharides, the algae powder, the nutritional amino acids and the like, thus being suitable for the hyperuricemia patients.
Description
Technical field
The present invention relates to a kind of special dietary seafood, especially relate to and a kind ofly can replenish the needed by human nutrient, improve the body nutrition condition, and utilize the function factor in the marine active polysaccharide to regulate body function, be fit to the edible sea dietary of hyperuricemia patients.
Background technology
Gout is the second largest metabolism class disease that is only second to diabetes, is because purine metabolic disturbance in the body, uric acid excretion disorder, the blood uric acid caused one group of syndrome that raises.When the uric acid content in the blood surpasses certain amount, uric acid precipitates at the slow or large position of vascular bending of blood flow in vivo, such as joint, subcutaneous, kidney tube wall etc., precipitation occurs in joint part and will cause urarthritis, and precipitation occurs in kidney and will cause gouty nephropathy.Gout has had a strong impact on Quality of Life, causes serious injury for patient's psychosomatic health.Gout is common chronic disease, and patient's normal life is affected, and has also increased country and patient's household economy burden simultaneously.
The generation of gout mainly is relevant with hyperuricemia in the body, cause that the reason that uric acid increases mainly is that uric acid generates too much and the minimizing of RE uric acid in the body, alkaline matter is conducive to acid-base value in the control agent, it can only be micro-pinch getting alkaline matter from normal meals, the special dietary seafood of preparation take alkaline matter as primary raw material, but just in the capacity and the uric acid in the body, promote the metabolism of uric acid, reduce serum Uric Acid Concentration, produce the effect of antigout.
Abroad, there are clear and definite regulation and perfect standard criterion in European and American developed countries to food for special foods, and generally accept for people.China has worked out " Chinese residents dietary guidelines " at present, and this guide was revised in 2007, take " packing in advance food for special foods label general rule GB 13432-2004 " as main regulatory documents.In this general rule, special diet is defined as: " be the physiological requirements of satisfying some special population, or the nutritional need of some Disease, press the food of the special processing of special formulation ".The science essence of special population diet regulation and control is: the control regular diet, replenish special diet, and strengthen for nutrition, reduce the metabolism burden, promote health strong.
Marine organisms are in the so special enclosed environment of seawater for a long time, the metabolic system different from terrestrial life and body defending system have been produced during evolution, therefore it is special to contain many functions in the marine organisms, the physiological activator that structure is special, at high salt, high pressure, anoxic, in the unglazed special ecological environment, the polysaccharide that marine organisms produce will born important physiological function, it is the important active material of a class, proved to have various physiological regulation functions from the isolated polysaccharide of various marine organisms, some is for improving the comprehensive physique of body, regulate uric acid level and have important function.Utilize scientifically and rationally marine bioactivity polysaccharide, have positive effect to improving body condition.
At present, seldom see the food take the marine active polysaccharide as primary raw material on the China market, in patent documentation and non-patent literature, all do not find to eat source property marine bioactivity polysaccharide and seawood meal yet and be that primary raw material is made, specially for the record of the edible special dietary seafood of hyperuricemia patients.
Summary of the invention
The deficiency that the objective of the invention is physilogical characteristics, nutritional need and conventional meals thereof for hyperuricemia patients, a kind of sea dietary of hyperuricemia patients special use is provided, this food has the body of improvement nutrition condition, and realization help body, reduction uric acid, conditioning engine body function of intestinal canal are waited until effect.
For reaching above-mentioned purpose, the sea dietary of a kind of hyperuricemia patients special use provided by the invention, be that to eat source property marine bioactivity polysaccharide be primary raw material, add seawood meal, be aided with again nutrition amino acid, compound sugar, vitamin and mineral matter and be mixed with and form.
The weight portion proportioning of the raw material of the sea dietary of hyperuricemia patients special use provided by the invention is:
Marine bioactivity polysaccharide 4.5-5.5
Seawood meal 1.5-2.5
Nutrition amino acid/11 .0-2.0
Compound sugar 1.0-2.0
Vitamin 0.01-0.10
Mineral matter 0.1-0.5.
Sea dietary of the present invention can be made powdery or granule state food, with edible after the warm water dissolving.
The primary raw material of sea dietary of the present invention is:
Marine bioactivity polysaccharide:
Marine bioactivity polysaccharide of the present invention is algal polysaccharides, a kind of in ocean shell class polysaccharide and the marine animal polysaccharide, several or whole, wherein said algal polysaccharides is agar, sodium alginate, carragheen, fucoidin, potassium alginate, calcium alginate, alginic acid zinc, a kind of in ferric alginate and the alginic acid magnesium, several or whole, described ocean shell class polysaccharide is pearl powder, nacreous layer powder, chitosan, a kind of in chitin oligo saccharide and the ammonia sugar, several or whole, described marine animal polysaccharide is one or both in glycosaminoglycan and the shark chondroitin.
Algal polysaccharides:
1) alginate, be present in a kind of natural polysaecharides material in the brown algas such as sea-tangle, bulk kelp, be the natural products that alginic acid in the frond and the mineral matter in the seawater generate, alginic acid gathers polysaccharide by mixing of forming of mannuronic acid (M) and guluronic acid (G).Algal polysaccharides is a kind of edible and don't by the macromolecular polysaccharide of human consumption, it has the effects such as water imbibition, adsorptivity, cationic exchange and gel filtration in stomach and intestine, have following functions: hypoglycemic, hypotensive, reducing blood lipid, reduce cholesterol, the prevention fatty liver; Hinder the absorption of radioactive element, help to get rid of heavy metal of body; Increase satiety, health slimming; Accelerate enterogastric peristalsis, Constipation.Have stronger biologically active through degraded alginate, have following obvious health-care effect: low molecular potassium alginate can adjusting and preventing hypertension, retarding cardiovascular old and feeble, improve microcirculation; But low molecule sodium alginate reducing blood lipid; Low molecule calcium alginate is the novel calcium source of supplementary calcium food, is easy to absorb; But low molecule alginic acid zinc brain tonic and intelligence development and prevention dementia of middle-and old aged man; Low molecule ferric alginate can be mended iron, enrich blood; Low molecule alginic acid magnesium can prevent and treat coronary heart disease.
2) fucoidin: fucoidin claims again fucoidin, algal polysaccharide sulfate, it is peculiar marine active polysaccharide in the brown algae sea-plant (sea-tangle etc.), belong to rare sulfuric ester ionic natural polysaccharide at occurring in nature, show that through great many of experiments and clinical research product has the immunity of raising, hypoglycemic, anticoagulation, reducing blood lipid, hypotensive, inhibition renal failure, the physiologically active such as antitumor.
3) carragheen: extract with red algaes such as Irish moss, by 1, the alternate straight-chain polysaccharide sulfuric ester that is combined into of 3-β-D-galactopyranose and Isosorbide-5-Nitrae-β-D-galactopyranose has anticoagulation and effect for reducing blood fat.Carragheen has the fundamental characteristics of soluble dietary fiber, and the carragheen after the degradation in vivo can form with fibrin the complex compound of solubility.Can be become CO by large enterobacteria glycolysis
2, H
2, the SCFA such as biogas and formic acid, acetic acid, propionic acid, become the energy source of probio.The carragheen imbibition also forms high viscosity and is stained with liquid, and the sense of obvious born of the same parents' abdomen is arranged under one's belt, can be used for fat-reducing.
Ocean shell class polysaccharide:
1) pearl powder
Pearl powder contains 18 seed amino acids, and wherein 7 kinds is the calcium carbonate of essential amino acid, aragonite structure, 20 various trace elements and Cobastab.The Pharmacopoeia of the People's Republic of China and " Chinese medicine voluminous dictionary " all indicate: pearl has the effects such as the arresting convulsion of calming the nerves, the screen that makes eye bright, detoxify and promote granulation, and modern study shows that also pearl powder is in the effect that improves body immunity, delays senility, the aspects such as freckle removing and whitening, supplement calcium all have uniqueness.Strengthen that immunity, supplement calcium, Bao Chunyan decline, improvement is slept, treat ulcer, nourish the liver to improve visual acuity, secondary buck.
2) chitosan, chitin oligo saccharide
Chitosan has the reinforced immunological function, to cancer inhibitory action arranged, suppress aging, reduce cholesterol, hypotensive activity, reinforcement liver function, to the regulating action of neural, internal system, improve have a pain in the back, harmful substance and be excluded in external in the adsorbent.
Chitosan is obtained chitin oligo saccharide through special biological enzyme technology processing, be water-soluble better, function is large, biologically active is high low molecular weight product, studies have shown that: chitin oligo saccharide has the immunity of raising, suppress the cancerous swelling Growth of Cells, promote liver spleen antibody to form, promote the absorption of calcium and mineral matter, human body beneficial's floras such as propagation Bifidobacterium, lactic acid bacteria, reducing blood lipid, hypotensive, hypoglycemic, adjusting cholesterol, fat-reducing, the functions such as prevention AD.
3) ammonia sugar
The full name of ammonia sugar is the D-Glucosamine, can be divided into D-Glucosamine Hydrochloride and D-aminoglucose sulfate.Ammonia sugar is the important component part of the extremely strong proteoglycan of hydrophily, and the collagen in its energy synthesized human very easily is absorbed by the body.Ammonia sugar is widely used as the nutritious supplementary pharmaceutical of articular cartilage, be the unique approval of American-European medical circle bone and joint diseases is had the nutrient and healthcare products of therapeutic action.
The marine animal polysaccharide:
1) glycosaminoglycan:
Isolate various glycosaminoglycans after extracting from the marine animals such as stichopus japonicus, sea cucumber, starfish, shark, cuttlefish, scallop, crustacean pteria martensii, it has the various active such as anticoagulation, antitumor, reducing blood lipid, raising immunity.
2) shark chondroitin:
Shark chondroitin has the diseases such as beautifying face and moistering lotion, strong muscles and bones, antirheumatic arthritis, pre-anti-cancer and tumour, coronary heart diseases and angina pectoris, myocardial infarction, coronary atherosclerosis, myocardial ischemia, without obvious toxic and side effect, can significantly reduce the M ﹠ M of patients with coronary heart disease.
Algal polysaccharides of the present invention refers to extract alginic acid and is combined with various mineral matter elements from marine alga, drying is pulverized the flour that is prepared from again.
Ocean of the present invention shell class polysaccharide refers to the flour that pearl or mother pearl shellfish are prepared from by physical method; Chitosan, chitin oligo saccharide and ammonia sugar are that chitin is passed through biochemical technology or biological enzymolysis technology, and drying is pulverized the flour that is prepared from again.
Marine animal polysaccharide of the present invention refers to sea mollusk, shellfish, fish-bone through enzymolysis, filtering albumen and purifying, again through Vacuum Concentration or spray-drying and the flour for preparing.
Seawood meal:
Food source property marine algae is rich in the trace elements such as algin, sweet mellow wine, vitamin and multi mineral prime element such as potassium, iron, calcium, phosphorus, iodine, selenium, cobalt, also contains crude protein 10%-40%, crude fat 0.30%-50%, carbohydrate 30%-60%.Scientific research shows, seawood meal can balance the body metabolic function, strengthen immunity, health care, benefit brain and enhancing intelligence, anti-ageing, can prevent thyroid gland enlargement, ephrosis, strengthening skin gloss and elasticity, softening blood vessel, reduction cholesterol, is a kind of cosmetic good merchantable brand; All right lipopenicillinase, step-down prevent obesity, hypertension, cardiovascular disease etc.
Seawood meal of the present invention is a kind of, several or whole in seawater spirulina powder, chlorella powder, Dunaliella peircei powder, ulva lactuca powder, Kelp Powder, skirt dish powder, laver powder, kelp powder, Algemin, pelvetia silquosa powder and the Eucheuma powder.
Seawood meal of the present invention refers to marine alga is cleaned, removes raw meat, filters flour assorted, that dry, pulverize and prepare.
Nutrition amino acid:
Amino acid is to consist of organism protein and with vital movement the most basic relevant material, is the base unit that consists of in vivo protein molecule, with the vital movement of biology close relationship arranged.It has special physiological function in antibody, be one of indispensable nutritional labeling in the organism, confirms through medical research, and L-arginine, taurine, ALANINE have the auxiliary function that reduces uric acid.
Nutrition amino acid of the present invention is a kind of, several or whole in L-arginine, taurine and the ALANINE.
Compound sugar:
Compound sugar claims again oligosaccharides.Functional oligose is not absorbed by human consumption, is not utilized by most enteron aisle spoilage organisms yet, thereby can suppress the spoilage organisms growth, helps to improve and keep the enteron aisle normal function.Long-term edible can delay senility, defaecation, lose weight, keep blood sugar level, improve the nutrient absorption rate, particularly can improve body to the absorption of calcium, iron, zinc ion.As flavor enhancement, avoided the drawback of the sweeteners such as sucrose with compound sugar with a lot of BAs.
Compound sugar of the present invention is a kind of, several or whole in malto-oligosaccharide, GOS, fructose oligosaccharides, oligoisomaltose, cow's milk compound sugar and the xylo-oligosaccharide.
Vitamin and mineral matter:
Vitamin and mineral matter are the nutrients of needed by human.
Vitamin of the present invention is vitamin A, vitamin D, vitamin E, vitamin C, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, a kind of, several or whole in nicotinic acid, folic acid, pantothenic acid, choline and the niacinamide element.
Mineral matter described in the present invention is a kind of, several or whole in calcium, potassium, magnesium, iron, zinc, selenium, manganese, copper, chromium and the molybdenum.
The interpolation form of mineral matter of the present invention is the organic or inorganic compound of this mineral matter.
The addition of vitamin and minerals (GB14880-1994) is carried out with " vitamin, mineral types and consumption " of " nutrient prime replenisher is declared and evaluated regulation (trying) " middle regulation that on July 1st, 2005, State Food and Drug Administration formally came into effect with reference to " DRIs ", " the food enrichment use sanitary standard " of Chinese Soclety of Nutrition's promulgation in 2000 among the present invention.
Above-mentioned various raw material mixes, and can keep its powdery, or through granulation, makes powdery or granule state food.
The sea dietary of hyperuricemia patients special use provided by the invention, achievement in research with reference to marine biology and marine life science, the achievement in research of modern nutriology and the traditional methods to keep in good health theory that keeps healthy is combined its characteristic and the effect of body is mainly manifested in the following aspects:
1, anti-trioxypurine
The present invention will have the anti-trioxypurine function various batchings carry out the science compatibility, various functions are merged, and by the synergy between the active ingredient, improve the effect of acid-base value and control uric acid in the control agent.
2, balanced in nutrition
Effectively replenish the hyperuricemia patients desired nutritional, improve nutrition condition, strengthen patient's resistance, be conducive to keep the enteron aisle normal function, simultaneously, by the synergy of marine bioactivity polysaccharide and the several functions factor, be conducive to control uric acid level, gout occurs in prevention.
3, be easy to absorb
Utilize prescription of the present invention, various components adopt the food of suitable ratio collocation preparation, ooze state through being after a certain amount of water-soluble solution to wait, and can arrive small intestine by stomach fast, absorb soon, can replenish rapidly the hyperuricemia patients desired nutritional.
4, strengthen immunity
Marine active polysaccharide in the present invention's prescription, physiological activator wherein has effect, seawood meal and the amino acid of building up resistance can improve immunity of organisms, compound sugar also can strengthen the many aspects such as synergy of immunity of organisms, marine active polysaccharose substance and the several functions factor by the growth and breeding that promotes beneficial bacteria of intestinal tract factor, can obviously strengthen the resistivity of body, the generation of the complication such as minimizing infection.
5, improve functions of intestines and stomach
Algal polysaccharides and seawood meal are rich in the ocean dietary fiber, has the very strong outlet capacity of tiing up, imbibition is original 50-200 times in intestines, form the very high colloidal solution of viscosity, with the large intestine contents mixed, increase the moisture of ight soil, because the moisture in the colloidal solution is difficult for being played by large intestinal absorption the effect of ight soil moisturizing.In addition, colloidal solution sticks on the large intestine inwall, plays the effect of lubricious enteron aisle, is conducive to the discharge of ight soil.Compound sugar suppresses the growth of spoilage organisms by promoting the growth and breeding of probio in the intestines, forms one protective barrier on the intestinal mucosa surface simultaneously, can resist the enteron aisle spoilage organisms to the damage of intestinal mucosa, reduces the absorption of intestinal toxic material.Compound sugar can promote intestines peristalsis, accelerates the discharge of residuals in the intestines, is conducive to prevent constipation.
The specific embodiment
Following examples only are used for setting forth the present invention, and protection scope of the present invention is not only to be confined to following examples.The those of ordinary skill of described technical field all can be realized purpose of the present invention according to above content disclosed by the invention and scope that each parameter is got.
Embodiment 1
The sea dietary (powdery) of preparation hyperuricemia patients special use
Present embodiment is selected powdery potassium alginate, shark chondroitin, pearl powder, ammonia sugar, chitosan, seawater spirulina powder, Algemin, Dunaliella peircei powder, Eucheuma powder, kelp powder, taurine, L-arginine, ALANINE, malto-oligosaccharide and various vitamin and mineral matter, presses column weight amount proportioning and is prepared:
(1) marine bioactivity polysaccharide: chitosan 2.0g, potassium alginate 1.5g, shark chondroitin 0.5g, pearl powder 0.5g, ammonia sugar 0.5g;
(2) seawood meal: seawater spirulina powder 0.5g, Algemin 0.5g, Dunaliella peircei powder 0.5g, kelp powder 0.3g, Eucheuma powder 0.2g;
(3) nutrition amino acid: taurine 1.0g, L-arginine 0.3g, ALANINE 0.2g;
(4) compound sugar: malto-oligosaccharide 1.5g;
(5) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
10.5mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg, niacinamide 0.5mg;
(6) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, manganese 1mg, chromium 0.01mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir, through super-dry, make powdered food.After about 150ml warm water dissolving, directly drink or take in through nasal feeding.
Embodiment 2
The sea dietary (graininess) of preparation hyperuricemia patients special use
Present embodiment is selected chitosan, potassium alginate, shark chondroitin, Algemin, Dunaliella peircei powder, Eucheuma powder, taurine, L-arginine, malto-oligosaccharide and various vitamin and the mineral matter of powdery, presses column weight amount proportioning and is prepared:
(1) marine bioactivity polysaccharide: chitosan 2.5g, potassium alginate 1.5g, shark chondroitin 1.0g;
(2) seawood meal: Algemin 1.0g, Dunaliella peircei powder 0.5g, Eucheuma powder 0.5g;
(3) nutrition amino acid: taurine 0.5g, L-arginine 0.5g;
(4) compound sugar: malto-oligosaccharide 1.5g;
(5) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
10.5mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg, niacinamide 0.5mg;
(6) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, manganese 1mg, chromium 0.01mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir, through granulation, drying, whole grain, granulation shape.After being used for the dissolving of 150ml warm water, directly drinking or take in through nasal feeding.
Embodiment 3
The sea dietary (powdery) of preparation hyperuricemia patients special use
Present embodiment is selected powdery ammonia sugar, calcium alginate, shark chondroitin, pearl powder, agar, chlorella powder, ulva lactuca powder, skirt dish powder, Algemin, pelvetia silquosa powder, taurine, malto-oligosaccharide, GOS, fructose oligosaccharides, oligoisomaltose, cow's milk compound sugar, xylo-oligosaccharide and various vitamin and mineral matter, presses column weight amount proportioning and is prepared:
(1) marine bioactivity polysaccharide: ammonia sugar 1.5g, calcium alginate 1.5g, shark chondroitin 0.5g, pearl powder 0.5g, agar 0.5g;
(2) seawood meal: chlorella powder 0.5g, ulva lactuca powder 0.5g, skirt dish powder 0.5g, Algemin 0.5g, pelvetia silquosa powder 0.5g;
(3) nutrition amino acid: taurine 1.0g;
(4) compound sugar: malto-oligosaccharide 0.5g, GOS 0.3g, fructose oligosaccharides 0.4g, oligoisomaltose 0.3g, cow's milk compound sugar 0.3g, xylo-oligosaccharide 0.2g;
(5) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
10.5mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg, niacinamide 0.5mg;
(6) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, manganese 1mg, chromium 0.01mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir, through super-dry, make powdered food.After about 150ml warm water dissolving, directly drink or take in through nasal feeding.
Embodiment 4
The sea dietary (graininess) of preparation hyperuricemia patients special use
Present embodiment is selected agar, sodium alginate, carragheen, fucoidin, potassium alginate, Algemin, L-arginine, taurine, ALANINE, malto-oligosaccharide, GOS, fructose oligosaccharides, oligoisomaltose and various vitamin and the mineral matter of powdery, presses column weight amount proportioning and is prepared:
(1) marine bioactivity polysaccharide: agar 1.5g, sodium alginate 1.5g, carragheen 1.0g, fucoidin 1.0g, potassium alginate 0.5g;
(2) seawood meal: Algemin 1.5g;
(3) nutrition amino acid: L-arginine 1.0g, taurine 0.5g, ALANINE 0.5g;
(4) compound sugar: malto-oligosaccharide 0.3g, GOS 0.2g, fructose oligosaccharides 0.3g, oligoisomaltose 0.2g;
(5) vitamin: vitamin A 0.2mg, vitamin E 3mg, vitamin C 30mg, vitamin D 0.1mg, Cobastab
10.5mg, Cobastab
20.5mg, Cobastab
60.5mg, Cobastab
120.1mg, nicotinic acid 0.5mg, folic acid 0.1mg, pantothenic acid 1mg, choline 50mg;
(6) mineral matter (the interpolation form of mineral matter is the organic or inorganic compound of this mineral matter): calcium 200mg, potassium 100mg, magnesium 100mg, iron 5mg, zinc 5mg, selenium 0.01mg, manganese 1mg, copper 0.1mg, molybdenum 0.01mg.
Above-mentioned raw materials is mixed, stir, through granulation, drying, whole grain, granulation shape.After being used for the dissolving of 150ml warm water, directly drinking or take in through nasal feeding.
Claims (4)
1. the sea dietary of a hyperuricemia patients special use, it is characterized in that eating source property marine bioactivity polysaccharide is primary raw material, add seawood meal, be aided with nutrition amino acid, compound sugar, vitamin and mineral matter again and be mixed with and form, the weight portion proportioning of described marine bioactivity polysaccharide, seawood meal, nutrition amino acid, compound sugar, vitamin and mineral matter is:
Described marine bioactivity polysaccharide is a kind of, several or whole in algal polysaccharides, ocean shell class polysaccharide and the marine animal polysaccharide, wherein said algal polysaccharides is a kind of, several or whole in agar, sodium alginate, carragheen, fucoidin, potassium alginate, calcium alginate, alginic acid zinc, ferric alginate and the alginic acid magnesium, described ocean shell class polysaccharide is chitosan, and described marine animal polysaccharide is one or both in glycosaminoglycan and the shark chondroitin;
Described seawood meal is a kind of, several or whole in seawater spirulina powder, chlorella powder, Dunaliella peircei powder, ulva lactuca powder, Kelp Powder, laver powder, Algemin and the pelvetia silquosa powder;
Described nutrition amino acid is a kind of, several or whole in L-arginine, taurine and the ALANINE.
2. the sea dietary of hyperuricemia patients special use according to claim 1 is characterized in that described compound sugar is a kind of, several or whole in malto-oligosaccharide, GOS, fructose oligosaccharides, oligoisomaltose, cow's milk compound sugar and the xylo-oligosaccharide.
3. the sea dietary of hyperuricemia patients special use according to claim 1 is characterized in that described vitamin is vitamin A, vitamin D, vitamin E, vitamin C, Cobastab
1, Cobastab
2, Cobastab
6, Cobastab
12, a kind of, several or whole in nicotinic acid, folic acid, pantothenic acid, choline and the niacinamide.
4. the sea dietary of hyperuricemia patients special use according to claim 1 is characterized in that described mineral matter is a kind of, several or whole in calcium, potassium, magnesium, iron, zinc, selenium, manganese, copper, chromium and the molybdenum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102907091A CN102077933B (en) | 2010-09-20 | 2010-09-20 | Special dietary seafood special for hyperuricemia patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010102907091A CN102077933B (en) | 2010-09-20 | 2010-09-20 | Special dietary seafood special for hyperuricemia patients |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102077933A CN102077933A (en) | 2011-06-01 |
| CN102077933B true CN102077933B (en) | 2013-04-24 |
Family
ID=44084284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010102907091A Expired - Fee Related CN102077933B (en) | 2010-09-20 | 2010-09-20 | Special dietary seafood special for hyperuricemia patients |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102077933B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102145010A (en) * | 2010-12-21 | 2011-08-10 | 李超群 | Use of combination of potassium and magnesium for preparing medicine for preventing or treating gout |
| CN102138938B (en) * | 2011-03-31 | 2013-04-10 | 中国海洋大学 | Composition for preparing products for improving hyperuricemia |
| CN102920743B (en) * | 2012-11-15 | 2015-11-18 | 浙江现代中药与天然药物研究院有限公司 | The application of spirulina in the anti-hyperuricemia of preparation and anti-gout drugs or health food |
| CN103652546B (en) * | 2013-09-29 | 2015-05-06 | 北京雷力联合海洋生物科技有限公司 | Nutrient composition as well as preparation method and application thereof |
| CN103920135B (en) * | 2014-04-23 | 2016-08-24 | 青岛昆布生物工程有限公司 | A kind of Thallus Laminariae (Thallus Eckloniae) amino composite sheet reducing uric acid content and preparation method thereof |
| CN104431170A (en) * | 2014-11-18 | 2015-03-25 | 杜小岗 | Marine bioactive polysaccharide or oligosaccharide granular tea drink for improving metabolic syndrome (six highs and one lipid) |
| CN104605370B (en) * | 2015-01-30 | 2017-03-22 | 曾晓飞 | Omega III fatty acid-rich nutrient enrichment food taking kappaphycus as main material |
| CN105982921A (en) * | 2015-02-25 | 2016-10-05 | 北京世健联合医学科学研究院（普通合伙） | Composition for treating gout and application thereof |
| CN105380962B (en) * | 2015-12-11 | 2019-02-22 | 汤臣倍健股份有限公司 | A kind of anti-trioxypurine composition and its preparation |
| CN105597081A (en) * | 2016-01-29 | 2016-05-25 | 程龙 | Medicine for reducing hypertension |
| CN105709207A (en) * | 2016-01-29 | 2016-06-29 | 徐宝贞 | Medicine for treating gout |
| CN105709206A (en) * | 2016-01-29 | 2016-06-29 | 程潜 | Medicine for treating fatty liver, hepatitis and liver cirrhosis |
| CN105997979A (en) * | 2016-06-28 | 2016-10-12 | 北京康力基生物科技有限公司 | Medicine composition, medicine containing medicine composition for regulating uric acid content in blood and application thereof |
| CN107088201A (en) * | 2017-04-24 | 2017-08-25 | 上海陶盛生物技术有限公司 | It is a kind of to be used to treat composition of gout and its production and use |
| CN108813442A (en) * | 2018-06-05 | 2018-11-16 | 青岛明月海藻生物科技有限公司 | A kind of light baking soda of seaweed |
| CN109452521B (en) * | 2018-12-26 | 2022-05-17 | 广东养慕特殊医用食品有限公司 | Auxiliary uric acid peptide reducing solid beverage, preparation method and application |
| CN109567208A (en) * | 2019-01-04 | 2019-04-05 | 广东海洋大学 | Enteral nutrition preparation and its preparation method and application containing marine bioactivity polysaccharide |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1655810A (en) * | 2002-05-20 | 2005-08-17 | 吗鲁哈株式会社 | Composition for treating or preventing hyperuricemia |
| CN1739556A (en) * | 2005-09-02 | 2006-03-01 | 颜怀玮 | Dietotherapeutic nutrient for preventing and treating secondary gout and its prepn process |
| CN101406309A (en) * | 2008-11-05 | 2009-04-15 | 昆明理工大学 | Method for preparing concentrated peptides of white fish and uses thereof |
| CN101692902A (en) * | 2009-09-05 | 2010-04-14 | 泰祥集团技术开发有限公司 | Food compositions for lowering and releasing uric acid and preventing gout |
-
2010
- 2010-09-20 CN CN2010102907091A patent/CN102077933B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1655810A (en) * | 2002-05-20 | 2005-08-17 | 吗鲁哈株式会社 | Composition for treating or preventing hyperuricemia |
| CN1739556A (en) * | 2005-09-02 | 2006-03-01 | 颜怀玮 | Dietotherapeutic nutrient for preventing and treating secondary gout and its prepn process |
| CN101406309A (en) * | 2008-11-05 | 2009-04-15 | 昆明理工大学 | Method for preparing concentrated peptides of white fish and uses thereof |
| CN101692902A (en) * | 2009-09-05 | 2010-04-14 | 泰祥集团技术开发有限公司 | Food compositions for lowering and releasing uric acid and preventing gout |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102077933A (en) | 2011-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102077933B (en) | Special dietary seafood special for hyperuricemia patients | |
| CN102077936B (en) | Special sea dietary food for diabetics | |
| CN102077940B (en) | Special dietary marine food for patients with coronary heart disease | |
| CN102077934B (en) | Special dietary marine food for patients with high blood pressure | |
| CN102077939B (en) | Marine special dietary food special for fat people | |
| CN102077945B (en) | Special dietary seafood for postabortal and postpartum women | |
| CN102077938B (en) | Special marine dietary food for patients with liver deficiency | |
| CN102077937B (en) | Special dietary seafood special for young and middle-aged women | |
| KR101870846B1 (en) | Multi-functional composition and preparation method and application thereof | |
| CN102077942B (en) | Marine special dietary food special for patient with bone disease | |
| CN107455698A (en) | A kind of ocean polypeptide spy's dietary seafood for being used to promote intelligence development | |
| CN102077944B (en) | Marine special dietary food special for prostate patient | |
| CN107495387A (en) | A kind of ocean polypeptide spy's dietary seafood as sports tonica | |
| CN107440107A (en) | It is a kind of to eat the food formula of special diet containing small peptide for pregnancy reaction crowd | |
| CN108095072A (en) | Small peptide spy's dietary seafood formula is eaten for long-term bed and muscle attenuation syndrome crowd | |
| CN107616507A (en) | A kind of ocean polypeptide spy's dietary seafood for chornic arthritis edible for patients | |
| CN102077943B (en) | Seafood for special dietary uses for hypomnesia patients | |
| CN104431170A (en) | Marine bioactive polysaccharide or oligosaccharide granular tea drink for improving metabolic syndrome (six highs and one lipid) | |
| CN102077935B (en) | Marine special dietary food special for vision recession patient | |
| CN100372541C (en) | Food for improving clinical conditions capable of lowering the concentration of low-molecular weight nitrogen-containing compounds in blood | |
| CN102077941B (en) | Special dietary seafood special for climacteric women | |
| CN107549692A (en) | A kind of ocean polypeptide spy's dietary seafood for patients undergoing chemotherapy post-operative recovery | |
| CN108576367A (en) | Fish polypeptide dry powder, anti-trioxypurine peptide combinations, beverage containing anserine and preparation method | |
| CN1718117A (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
| CN104839709A (en) | Gastrointestinal absorption barrier non-total nutrient formula food |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20110601 Assignee: Guangzhou Blue Key Ocean Bioengineering Co., Ltd. Assignor: Wang Qiang Contract record no.: 2015990001022 Denomination of invention: Special dietary seafood special for hyperuricemia patients Granted publication date: 20130424 License type: Exclusive License Record date: 20151210 |
|
| LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20160824 Address after: 510300, room 11, 1710 art street, Xingang Middle Road, Guangzhou, Guangdong, Haizhuqu District Patentee after: Guangzhou Blue Key Ocean Bioengineering Co., Ltd. Address before: 1710, room 11, block A, arts street, No. 510300, Xingang Road, Guangzhou, Guangdong Patentee before: Wang Qiang |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130424 Termination date: 20190920 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |